المؤلفون: Sonnemann HM; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Pazdrak B; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Nassif B; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Sun Y; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States.; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Elzohary L; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Talukder AH; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Katailiha AS; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States., Bhat K; Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, United States., Lizée G; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, United States.; Department of Immunology, UT MD Anderson Cancer Center, Houston, TX, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 Jun 07; Vol. 14, pp. 1403052. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Sonnemann HM; UTHealth Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Pazdrak B; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA; Department of Computer Science, Rice University, Houston, TX, USA., Roszik J; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Lizée G; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, UT MD Anderson Cancer Center, Houston, TX, USA. Electronic address: glizee@mdanderson.org.

المصدر: Biochimica et biophysica acta. Reviews on cancer [Biochim Biophys Acta Rev Cancer] 2023 May; Vol. 1878 (3), pp. 188892. Date of Electronic Publication: 2023 Mar 31.

نوع المنشور: Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9806362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2561 (Electronic) Linking ISSN: 0304419X NLM ISO Abbreviation: Biochim Biophys Acta Rev Cancer Subsets: MEDLINE

مواضيع طبية MeSH: DNA-Binding Proteins*/genetics , DNA-Binding Proteins*/metabolism , Neoplasms*/genetics, Animals ; Female ; Humans ; Pregnancy ; Placenta/metabolism ; Transcription Factors/genetics ; Transcription Factors/metabolism ; TEA Domain Transcription Factors ; Mammals/metabolism

المؤلفون: Jackson KR; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Antunes DA; Department of Biology and Biochemistry, University of Houston, Houston, TX, USA., Talukder AH; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Maleki AR; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Amagai K; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Salmon A; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Katailiha AS; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Chiu Y; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Fasoulis R; Department of Computer Science, Rice University, Houston, TX, USA., Rigo MM; Department of Computer Science, Rice University, Houston, TX, USA., Abella JR; Department of Computer Science, Rice University, Houston, TX, USA., Melendez BD; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Li F; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Sun Y; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Sonnemann HM; University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Belousov V; BostonGene Corporation, Waltham, MA, USA., Frenkel F; BostonGene Corporation, Waltham, MA, USA., Justesen S; Immunitrack Aps, Copenhagen, Denmark., Makaju A; ThermoFisher Scientific, San Jose, CA, USA., Liu Y; ThermoFisher Scientific, San Jose, CA, USA., Horn D; ThermoFisher Scientific, San Jose, CA, USA., Lopez-Ferrer D; ThermoFisher Scientific, San Jose, CA, USA., Huhmer AF; ThermoFisher Scientific, San Jose, CA, USA., Hwu P; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Roszik J; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA., Hawke D; Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Kavraki LE; Department of Computer Science, Rice University, Houston, TX, USA., Lizée G; Department of Melanoma, UT MD Anderson Cancer Center, Houston, TX, USA.

المصدر: PNAS nexus [PNAS Nexus] 2022 Jul 27; Vol. 1 (3), pp. pgac124. Date of Electronic Publication: 2022 Jul 27 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press on behalf of the National Academy of Sciences Country of Publication: England NLM ID: 9918367777906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2752-6542 (Electronic) Linking ISSN: 27526542 NLM ISO Abbreviation: PNAS Nexus Subsets: PubMed not MEDLINE

المؤلفون: Ratnam NM; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Sonnemann HM; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Frederico SC; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Chen H; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Hutchinson MND; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Dowdy T; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Reid CM; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Jung J; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Zhang W; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Song H; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Zhang M; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Davis D; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Larion M; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Giles AJ; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, Bethesda, MD, United States.

المصدر: Frontiers in oncology [Front Oncol] 2021 Jul 15; Vol. 11, pp. 719091. Date of Electronic Publication: 2021 Jul 15 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Li F; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Deng L; Tianjin HengJia Biotechnology Development Co Ltd, Tianjin, China., Jackson KR; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Talukder AH; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Katailiha AS; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bradley SD; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zou Q; Tianjin HengJia Biotechnology Development Co Ltd, Tianjin, China., Chen C; Tianjin HengJia Biotechnology Development Co Ltd, Tianjin, China., Huo C; Tianjin HengJia Biotechnology Development Co Ltd, Tianjin, China., Chiu Y; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stair M; Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, USA., Feng W; Department of Oncology, Tianjin Beichen Hospital, Tianjin, China., Bagaev A; BostonGene Corporation, Waltham, Massachusetts, USA., Kotlov N; BostonGene Corporation, Waltham, Massachusetts, USA., Svekolkin V; BostonGene Corporation, Waltham, Massachusetts, USA., Ataullakhanov R; BostonGene Corporation, Waltham, Massachusetts, USA., Miheecheva N; BostonGene Corporation, Waltham, Massachusetts, USA., Frenkel F; BostonGene Corporation, Waltham, Massachusetts, USA., Wang Y; Tianjin HengJia Biotechnology Development Co Ltd, Tianjin, China., Zhang M; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hawke D; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Han L; Department of Oncology, Tianjin Beichen Hospital, Tianjin, China., Zhou S; Provincial Clinical College, Fujian Medical University, Fujian, China., Zhang Y; State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China., Wang Z; Biological Sample Resource Sharing Center, Tianjin First Central Hospital, Tianjin, China., Decker WK; Department of Immunology, Baylor College of Medicine, Houston, Texas, USA., Sonnemann HM; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roszik J; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Forget MA; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies MA; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bernatchez C; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yee C; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bassett R; Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Hwu P; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Du X; Department of Oncology, Tianjin Beichen Hospital, Tianjin, China glizee@mdanderson.org dudaming73@163.com., Lizee G; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA glizee@mdanderson.org dudaming73@163.com.; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Cancer Vaccines/pharmacology ; Carcinoma, Non-Small-Cell Lung/pathology ; ErbB Receptors/metabolism ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Mutation

المؤلفون: Bradley SD; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Talukder AH; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Lai I; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Davis R; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Alvarez H; Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA., Tiriac H; Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, NY, USA., Zhang M; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Chiu Y; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Melendez B; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Jackson KR; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Katailiha A; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Sonnemann HM; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Li F; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Kang Y; Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Qiao N; Department of Breast Surgery Research, UT MD Anderson Cancer Center, Houston, TX, USA., Pan BF; Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Lorenzi PL; Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Hurd M; Ahmed Center for Pancreatic Cancer Research, UT MD Anderson Cancer Center, Houston, TX, USA., Mittendorf EA; Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Peterson CB; Department of Biostatistics, UT MD Anderson Cancer Center, Houston, TX, USA., Javle M; Department of Gastrointestinal Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Bristow C; Center for Co-clinical Trials, UT MD Anderson Cancer Center, Houston, TX, USA., Kim M; Department of Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Tuveson DA; Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, NY, USA., Hawke D; Department of Systems Biology, UT MD Anderson Cancer Center, Houston, TX, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Wolff RA; Department of Gastrointestinal Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Hwu P; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Maitra A; Department of Pathology, UT MD Anderson Cancer Center, Houston, TX, USA., Roszik J; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Yee C; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. cyee@mdanderson.org.; Department of Immunology, UT MD Anderson Cancer Center, Houston, TX, USA. cyee@mdanderson.org., Lizée G; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA. glizee@mdanderson.org.; Department of Immunology, UT MD Anderson Cancer Center, Houston, TX, USA. glizee@mdanderson.org.

المصدر: Nature communications [Nat Commun] 2020 Oct 21; Vol. 11 (1), pp. 5332. Date of Electronic Publication: 2020 Oct 21.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*immunology , Breast Neoplasms/*immunology , DNA-Binding Proteins/*immunology , Pancreatic Neoplasms/*immunology , Transcription Factors/*immunology, Antigens, Neoplasm/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/immunology ; Breast Neoplasms/genetics ; Carcinoma, Pancreatic Ductal/genetics ; Carcinoma, Pancreatic Ductal/immunology ; Carcinoma, Pancreatic Ductal/therapy ; Cell Line, Tumor ; Cytotoxicity, Immunologic ; DNA-Binding Proteins/genetics ; Female ; Gene Expression Profiling ; HLA-A1 Antigen/immunology ; Humans ; Immunotherapy, Adoptive ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/therapy ; Placenta/immunology ; Pregnancy ; Prognosis ; T-Lymphocytes, Cytotoxic/immunology ; Transcription Factors/genetics ; Pancreatic Neoplasms

المؤلفون: Giles AJ; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA. amber.giles@nih.gov., Hutchinson MND; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Sonnemann HM; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Jung J; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Fecci PE; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Ratnam NM; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Zhang W; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Song H; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Bailey R; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Davis D; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Reid CM; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Park DM; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA., Gilbert MR; Neuro-Oncology Branch, CCR, NCI, National Institutes of Health, 37 Convent Dr. Bldg. 37, Rm. 1142B, Bethesda, MD, 20892, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 11; Vol. 6 (1), pp. 51. Date of Electronic Publication: 2018 Jun 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Dexamethasone/*therapeutic use , Immunosuppression Therapy/*methods , Immunotherapy/*methods, Animals ; Dexamethasone/pharmacology ; Disease Models, Animal ; Female ; Humans ; Mice